Profil
Michael Holdbrook worked as a Senior Director-Clinical Affairs & Biostatistics at Oculeve, Inc. from 2014 to 2017.
He then served as a Vice President at Experien Group LLC.
In 2018, he joined Tarsus Pharmaceuticals, Inc. as a Senior Vice President-Clinical Affairs, where he worked until 2023.
Mr. Holdbrook completed his undergraduate degree at the University of California San Diego.
Anciens postes connus de Michael Holdbrook
| Sociétés | Poste | Fin |
|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/04/2023 |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment | Corporate Officer/Principal | 01/10/2017 |
Experien Group LLC
Experien Group LLC Miscellaneous Commercial ServicesCommercial Services Provides regulatory, quality and clinical consulting services | Corporate Officer/Principal | - |
Formation de Michael Holdbrook
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Experien Group LLC
Experien Group LLC Miscellaneous Commercial ServicesCommercial Services Provides regulatory, quality and clinical consulting services | Commercial Services |
Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis | Health Technology |
















